1. Home
  2. CHMI vs IMUX Comparison

CHMI vs IMUX Comparison

Compare CHMI & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cherry Hill Mortgage Investment Corporation

CHMI

Cherry Hill Mortgage Investment Corporation

HOLD

Current Price

$2.76

Market Cap

83.3M

Sector

Real Estate

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$0.69

Market Cap

85.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHMI
IMUX
Founded
2012
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.3M
85.8M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
CHMI
IMUX
Price
$2.76
$0.69
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$3.00
$6.00
AVG Volume (30 Days)
198.9K
1.6M
Earning Date
03-05-2026
02-14-2026
Dividend Yield
14.81%
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$40,202,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$31.73
N/A
P/E Ratio
$144.11
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.17
$0.51
52 Week High
$3.68
$1.39

Technical Indicators

Market Signals
Indicator
CHMI
IMUX
Relative Strength Index (RSI) 59.78 57.66
Support Level $2.65 $0.59
Resistance Level $2.77 $0.71
Average True Range (ATR) 0.08 0.05
MACD 0.00 0.01
Stochastic Oscillator 88.68 76.31

Price Performance

Historical Comparison
CHMI
IMUX

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: